TrialInflammatory bowel diseases2022

Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.

Stefanie Howaldt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.